This project is to be funded under the BBSRC Doctoral Training Partnership. If you are interested in this project, please make direct contact with the Principal Supervisor to arrange to discuss the project further as soon as possible. You MUST also submit an online application form - full details on how to apply can be found on the BBSRC DTP website View Website
As an equal opportunities institution we welcome applicants from all sections of the community regardless of gender, ethnicity, disability, sexual orientation and transgender status. All appointments are made on merit.
1) Munro AW et al. (2002), P450 BM3: the very model of a modern flavocytochrome. Trends Biochem. Sci. 27, 250-257.
2) Girvan HM and Munro AW (2016), Applications of cytochrome P450 enzymes in biotechnology and synthetic biology. Curr. Opin. Chem. Biol. 31, 136-145.
3) Richards L et al. (2019), Production of metabolites of the anti-cancer drug noscapine using a P450 BM3 mutant library. Biotechnol. Rep. 24:e00372.
4) Butler CF et al. (2013), Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias. J. Biol. Chem. 288, 25387-25399.
5) Butler CF et al. (2014), Human P450-like oxidation of diverse proton pump inhibitor drugs by ‘gatekeeper’ mutants of flavocytochrome P450 BM3. Biochem. J. 460, 247-259.